TITLE

Insights into US public biotech sector using patenting trends

AUTHOR(S)
Aggarwal, Saurabh; Gupta, Vinay; Bagchi-Sen, Sharmistha
PUB. DATE
June 2006
SOURCE
Nature Biotechnology;Jun2006, Vol. 24 Issue 6, p643
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article provides information on the patenting trends of public biotechnology sector in the U.S. The biotechnology companies played an important role in research and developments for drugs, technologies and tools. An analysis on the patent data from 1995-2005, which was obtained from the U.S. Patent and Trade Organization, showed that small and medium-sized companies gave importance of intellectual property protection.
ACCESSION #
21143599

 

Related Articles

  • Legal and regulatory update.  // Journal of Commercial Biotechnology;Winter2002, Vol. 8 Issue 3, p250 

    Presents updates on several legal and regulatory issues concerning the biotechnology industry, as of January 2002. Pharmaceutical patent claims; Consolidation and amendment of the regulatory framework for medicinal products; Publication of guidelines for intellectual property rights in Great...

  • European Industry Lagging In Race For Intellectual Property. Moran, Nuala // BioWorld International;5/9/2007, Vol. 12 Issue 19, p1 

    The article discusses the result of a study on biotechnology-oriented patents and trademarks released at the BIO 2007 Convention held in Boston, Massachusetts on May 7. The study concluded that biotechnology industry in Europe is falling further behind its U.S. counterpart in the competition to...

  • Start-Up Biotechs May Face Rock-Hard Patent Quandary. Serebrov, Mari // BioWorld Insight;3/12/2012, Vol. 20 Issue 11, p3 

    The article discusses the patent system and its impact on biotech industries. A first-to-file patent system in the U.S. has increased the problems due to the uncertainty caused by its standard and the harm it can cause to the intellectual property. The new standards which are imposed by the...

  • Patent term extensions for biologic innovators in Japan. Tessensohn, John A.; Yamamoto, Shusaku // Nature Biotechnology;Jan2011, Vol. 29 Issue 1, p34 

    The article considers the benefit of the decisions by the Intellectual Property High Court of Japan upholding the market exclusivity period for the brand biologic Enbrel (etanercept) to the biotechnology industry in 2011. The establishment of the Japanese patent term extension (PTE) and...

  • How Much Intellectual Property Protection Do the Newest (and Coolest) Biotechnologies Get Internationally? Weisfeld, Alix // Chicago Journal of International Law;Winter2006, Vol. 6 Issue 2, p833 

    Information on the intellectual property protection the biotechnology companies get internationally is presented. It offers information on biologics and pharmacogenetics. It examines the regulatory protections given to pharmaceuticals in the U.S. and abroad. It considers what patent protections...

  • Patent law in dentistry: An overview. Bijle, Mohammed Nadeem A. // Indian Journal of Dental Research;Jul/Aug2011, Vol. 22 Issue 4, p574 

    Dentistry in recent years has developed interest in the field of intellectual property rights (IPR) and Patents due to extensive research in the fraternity and existing competition. There have been various patent applications and grants in the field of dentistry abroad due to better...

  • USING THE WRITTEN DESCRIPTION REQUIREMENT TO LIMIT BROAD PATENT SCOPE, ALLOW COMPETITION, AND ENCOURAGE INNOVATION IN BIOTECHNOLOGY. Mull, William C. // Health Matrix: Journal of Law-Medicine;Summer2004, Vol. 14 Issue 2, p393 

    Discusses the U.S. Court of Appeals for the Federal Circuit's use of the written description requirement of the Patent Act to limit the scope of biotechnology patents. Significance of patent protection to the biotechnology industry; Overview of biotechnology and the basics of patent law;...

  • Biotechnology's Uncertainty principle. Burk, Dan L.; Lemley, Mark A. // Case Western Reserve Law Review;Spring2004, Vol. 54 Issue 3, p691 

    Discusses the uncertainty of the patent standards covering the products of the biotechnology industries in the U.S. Formulation of legal rules in the patent law to govern the validity and infringement of patents in a wide variety of technologies; Failure of the statute to distinguish between...

  • Changes to Patent System May Harm Biotechs. Weeks, Katie // San Diego Business Journal;5/8/2006, Vol. 27 Issue 19, p17 

    The article reports on the changes made for the patent systems in the biotechnology company proposed by the U.S. House of Representatives and the U.S. Patent and Trademark Office. One of the proposed changes is to choose a system that grants patents based on the first person to file instead of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics